Hypofractionated Radiation Therapy for Prostate Cancer in the Postoperative Setting: Is It Capable of Going the Distance?
0/5 보강
APA
Achard V, Benziane-Ouaritini N, Sargos P (2025). Hypofractionated Radiation Therapy for Prostate Cancer in the Postoperative Setting: Is It Capable of Going the Distance?. International journal of radiation oncology, biology, physics, 123(2), 381-383. https://doi.org/10.1016/j.ijrobp.2025.04.042
MLA
Achard V, et al.. "Hypofractionated Radiation Therapy for Prostate Cancer in the Postoperative Setting: Is It Capable of Going the Distance?." International journal of radiation oncology, biology, physics, vol. 123, no. 2, 2025, pp. 381-383.
PMID
40914578
같은 제1저자의 인용 많은 논문 (3)
- Re: Amar U. Kishan, Luca F. Valle, Holly Wilhalme, et al. Lu-Prostate-specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-label, Randomized, Controlled, Phase II Study. J Clin Oncol 2025;43:3812-21.
- Postoperative Radiation Therapy and Controversies Regarding Hormonal Therapy in the Management of Prostate Cancer.
- SBRT in oligometastatic castration-resistant prostate cancer.